Cardiovascular surgery in Turner syndrome - early outcome and long-term follow-up

Margaret M Fuchs1, Christine Helena Attenhofer Jost2, Sameh M Said3

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, United States. fuchs.margaret@mayo.edu.

Insights

Cardiovascular surgery in Turner syndrome (TS) patients has an 8% early mortality risk due to complex medical conditions. Survivors experience good long-term survival, but reoperations are common.

Area of Science:

  • Cardiology
  • Genetics
  • Surgical Outcomes

Background:

  • Cardiovascular disease is a primary cause of mortality in Turner syndrome (TS).
  • TS patients present with complex comorbidities complicating surgical care.
  • Cardiovascular surgery is frequently necessary for TS management.

Purpose of the Study:

  • To evaluate cardiovascular surgical outcomes in patients with Turner syndrome.
  • To analyze mortality and reoperation rates following cardiovascular surgery in TS.

Main Methods:

  • Retrospective case series of 51 TS patients undergoing cardiovascular surgery (1977-2017).
  • Review of clinical data, echocardiograms, operative reports, and hospital courses.
  • Kaplan-Meier survival analysis for long-term mortality and reoperation rates.

Main Results:

  • Common procedures included aortic coarctation repair, aortic valve replacement, and aortic root/ascending aorta replacement.
  • Early surgical mortality was 8% (4 patients).
  • 10- and 20-year freedom from death was 97% and 89%; freedom from reoperation was 93% and 81%.

Conclusions:

  • Cardiovascular surgery in TS patients carries an 8% early mortality risk due to medical complexity.
  • Patients surviving initial surgery demonstrate favorable long-term survival.
  • Late cardiovascular reoperations are frequently required in this population.
Abstract